Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BENEDICT: Trandolapril and Verapamil in Diabetic Nephropathy
NCT00235014Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 1997
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of trandolapril, verapamil in diabetic nephropathy (DN), sponsored by Abbott Laboratories. Started Mar 1997; status: completed.
02
Drugs
trandolaprilverapamil
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00235014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235014.